31
Participants
Start Date
October 31, 2013
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Basiliximab
20 mg, IV (in the vein) on day 1 and 4.
Methylprednisolone
125 mg, IV (in the vein) on day 1.
Prednisone
60 mg PO (by mouth) on days 2-7, 40 mg PO days 8-14, 20 mg PO days 15-21, and 10mg PO days 22-28.
Tacrolimus
1-5 mg PO, twice a day (BID) days 2-180.
Mycophenolate mofetil
500 mg PO, BID days 2-7, 500 mg PO each morning and 1000 mg each night, days 8-14, 1000 mg PO BID days 15-180.
Emory University, Atlanta
Massachusetts General Hospital, Boston
University of Massachusetts Medical School, Worcester
ALS Association
OTHER
Emory University
OTHER